ORAL PHARMACEUTICAL DOSAGE FORMS OF BUDESONIDE

The present invention relates to novel oral sustained release pharmaceutical dosage forms for delivery of budesonide to the lower gastrointestinal tract for the treatment of Crohn's disease.

Saved in:
Bibliographic Details
Main Authors KULKARNI, Shirish, SHARMA, Mukesh, KULKARNI, Amol, KANERIA, Vimal, THENNATI, Rajamannar
Format Patent
LanguageEnglish
French
German
Published 18.07.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel oral sustained release pharmaceutical dosage forms for delivery of budesonide to the lower gastrointestinal tract for the treatment of Crohn's disease.
Bibliography:Application Number: EP20160843858